from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2025c/-

LFCtreatmentdescriptionclass of inhibitor

-0.606

Amikacinug/mL Amikacintranslation

-0.801

Cap5-10ug/mL Capreomycintranslation

-0.518

Rox10-50 ug/mL Roxithromycintranslation

-0.593

SM2-5 ug/mL Streptomycintranslation

-0.702

Tet5-10 ug/mL Tetracyclinetranslation

0.771

Rif0.2-5ug/mL Rifampicintranscription

0.293

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.470

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.228

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.384

CPZ10-50 ug/mL Chlorpromazinerespiration

0.635

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.058

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.687

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.013

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.896

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.252

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.073

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.409

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.086

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.608

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.519

KCN5-20 ug/mL Potassium cyaniderespiration

-0.365

NaN30.2-2 mM Sodium aziderespiration

-0.703

Nigericin50 uM Nigericinrespiration

0.941

TRC10-150 ug/mL Triclosanrespiration

0.845

TRZ10-25 ug/mL Thioridazinerespiration

1.478

Valinomycin0.5-10 uM Valinomycinrespiration

-1.707

ZnSO42 mM ZnSO4respiration

0.535

menadione6-10 ug/mL Menadionerespiration

-0.224

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.500

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.040

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.794

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.531

NRP_1Non-replicating persistence stage 1dosRassociated

-0.096

Amp0.2mg/mL AmpicillincellWall

-0.354

Cephalexin20-100 ug/mL CephalexincellWall

-0.555

Cerulenin0.32-5 ug/mL CerulenincellWall

1.081

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.347

EMB10-20 ug/mL EthambutolcellWall

-1.017

Eta12-40 ug/mL EthionamidecellWall

-0.949

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.215

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.757

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.777

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.001

BZA0.12 mg/mL BenzamidearomaticAmides

0.075

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.459

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.108

H2O24 mM hydrogen peroxideDNAdamaging

-0.473

Levo10 ug/mL LevofloxacinDNAdamaging

-0.698

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.046

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.330

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.522

UVUV-irradiationDNAdamaging

0.978

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.277

Antimycin12.5-50 ug/mL Antimycin A?

-0.051

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.285

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.192

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.128

PA8240.2-2 ug/mL PA-824?

-0.263

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.194

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.194

Verapamil50 uM Verapamil?

0.225

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.995

methoxatin10-20 ug/mL Methoxatin?